RecruitingNot ApplicableNCT07754318

Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA)

Sponsor

Medtronic Cardiovascular

Enrollment

142 participants

Start Date

Aug 26, 2026

Study Type

INTERVENTIONAL

Conditions

AAA - Abdominal Aortic Aneurysm

Summary

To evaluate the safety and effectiveness of the Heli-FX EndoAnchor system in AAA subjects who without augmented radial fixation and/or sealing due to an endoleak or migration are at high risk for aneurysm-related complications or who are at high risk of migration or endoleak complications post-procedure, and to support product registration of Heli-FX EndoAnchor system with the National Medical Product Administration (NMPA) in China.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Heli-FX EndoAnchor System for people with aaa - abdominal aortic aneurysm. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.